Valion Bio, Inc. (VBIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$4.47M
Year ended 2024-12-31
2022-12-31: -$10.09M2023-12-31: -$8.24M2024-12-31: -$4.47M-$4.47M
2022-12-31 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$4.47Mn/c2026-03-30, From 2024-01-01
2023-12-31-$8.24Mn/m2025-03-21, From 2023-01-01
2022-12-31-$10.09Mn/a2024-03-25, From 2022-01-01